BACKGROUND In 1981, Mitrofanoff described a procedure to create a continent urinary stoma for clean intermittent catheterization. Since then several procedures have been described including Yang-Monti ileovesicostomy for effective catheterization. OBJECTIVES We report on our experience from the use of Monti's procedure in children at our center. PATIENTS AND METHODS Children < 18 years of a...

The most effective local treatment of muscle invasive bladder cancer and non-invasive, high-grade bladder tumours that recur or progress despite intravesical therapies, is open radical cystectomy (RC), extended pelvic lymph node (LN) dissection with urinary diversion. Performing these complex procedures using pure laparoscopy is extremely difficult. On the other hand, the surgical robot has the...

BACKGROUND Surgery performed to improve or replace the function of the diseased urinary bladder has been carried out for over a century. Main reasons for improving or replacing the function of the urinary bladder are bladder cancer, neurogenic bladder dysfunction, detrusor overactivity and chronic inflammatory diseases of the bladder (such as interstitial cystitis, tuberculosis and schistosomia...

Orthotopic neobladder substitution represents an important step in the evolution of urinary diversion. It is now considered the diversion of choice for themajority of patients, bothmale and female, who undergo cystectomy and is the procedurewith which other types of diversion must be compared. Nevertheless, in the preoperative setting, all options for urinary diversion should be explained compr...

Stricture of the proximal urethra following treatment for prostate cancer occurs in an estimated 1-8% of patients. Following prostatectomy, urethral reconstruction is feasible in many patients. However, in those patients with prior radiation therapy (RT), failed reconstruction, refractory incontinence or multiple comorbidities, reconstruction may not be feasible. The purpose of this article is ...

BACKGROUND Health-related quality of life (HRQOL) has not been adequately measured in bladder cancer. A recently developed reliable and disease-specific quality of life instrument (Bladder Cancer Index, BCI) was used to measure urinary, sexual, and bowel function and bother domains in patients with bladder cancer managed with several different interventions, including cystectomy and endoscopic-...